deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00323531

Thoracoscopy Versus Fibrinolysis in Children With Empyema

Sponsor: Children's Mercy Hospital Kansas City

Conditions Empyema
Interventions Chest tube with tPA infusion for 3 days VATS decortication
Updated 5 times since 2017 Last updated: May 6, 2008 Started: Mar 31, 2006 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00323531, this PHASE2/PHASE3 trial focuses on Empyema and remains completed. Sponsored by Children's Mercy Hospital Kansas City, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Mercy Hospital Kansas City
Data source: Children's Mercy Hospital Kansas City

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations